On November 10, 2025, Elevance Health, Inc. reaffirmed its earnings guidance for 2025, estimating approximately $24.70 per diluted share, including about $5.30 of unfavorable items. Adjusted earnings are expected to be around $30.00 per diluted share, with a benefit expense ratio of about 90%.